Dreyling, Martin 1961-
Dreyling, Martin.
Martin Dreyling
VIAF ID: 33204456 ( Personal )
Permalink: http://viaf.org/viaf/33204456
Preferred Forms
-
- 100 1 _ ‡a Dreyling, Martin
- 100 1 _ ‡a Dreyling, Martin
-
- 100 1 _ ‡a Dreyling, Martin ‡d 1961-
-
- 100 0 _ ‡a Martin Dreyling
4xx's: Alternate Name Forms (13)
Works
Title | Sources |
---|---|
Ibrutinib eine neue orale Therapieoption bei CLL und beim MCL | |
Indolente Non-Hodgkin-Lymphome | |
Maligne Lymphome | |
Mantelzell-Lymphom (MCL) | |
Nowo rozpoznany lub nawrotowy chłoniak grudkowy : zalecenia European Society for Medical Oncology (ESMO) z 2010 r. = Newly diagnosed and relapsed follicular lymphoma : ESMO clinical practice guidelines diagnosis, treatment and follow-up | |
Obinutuzumab (Gazyvaro) bei Patienten mit follikulärem Lymphom (FL) | |
A Phase II study to assess the safety and efficacy of the dual mTORC1/2 and PI3K inhibitor bimiralisib (PQR309) in relapsed, refractory lymphoma | |
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial | |
Rare lymphomas, 2014: | |
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen BTK-Hemmung: Schlüssel zur CLL-Primärtherapie? |